Fradet Y - Search Results

1

Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.

Habuchi T, Marberger M, Droller MJ, Hemstreet GP 3rd, Grossman HB, Schalken JA, Schmitz-Dräger BJ, Murphy WM, Bono AV, Goebell P, Getzenberg RH, Hautmann SH, Messing E, Fradet Y, Lokeshwar VB. Habuchi T, et al. Among authors: fradet y. Urology. 2005 Dec;66(6 Suppl 1):64-74. doi: 10.1016/j.urology.2005.08.065. Urology. 2005. PMID: 16399416

2

Intermediate endpoint biomarkers for chemoprevention.

Hemstreet GP 3rd, Rao JY, Hurst RE, Bonner RB, Jones PL, Vaidya AM, Fradet Y, Moon RC, Kelloff GJ. Hemstreet GP 3rd, et al. Among authors: fradet y. J Cell Biochem Suppl. 1992;16I:93-110. doi: 10.1002/jcb.240501320. J Cell Biochem Suppl. 1992. PMID: 1305696 Review.

3

Markers of prognosis in superficial bladder cancer.

Fradet Y. Fradet Y. Semin Urol. 1992 Feb;10(1):28-38. Semin Urol. 1992. PMID: 1565901 Review. No abstract available.

4

Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.

Huland E, Huland H, Meier T, Baricordi O, Fradet Y, Grossman HB, Hodges GM, Messing EM, Schmitz-Draeger BJ. Huland E, et al. Among authors: fradet y. J Urol. 1991 Dec;146(6):1631-6. doi: 10.1016/s0022-5347(17)38202-2. J Urol. 1991. PMID: 1719252

5

The etiology of bladder cancer--are there any new clues or predictors of behavior?

Shirai T, Fradet Y, Huland H, Bollack C, Droller M, Janknegt R, Jones P, Kagawa S. Shirai T, et al. Among authors: fradet y. Int J Urol. 1995 Jun;2 Suppl 2:64-75. doi: 10.1111/j.1442-2042.1995.tb00481.x. Int J Urol. 1995. PMID: 7553307 Free article. Review.

6

Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis.

Rao JY, Hemstreet GP 3rd, Hurst RE, Bonner RB, Jones PL, Min KW, Fradet Y. Rao JY, et al. Among authors: fradet y. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8287-91. doi: 10.1073/pnas.90.17.8287. Proc Natl Acad Sci U S A. 1993. PMID: 8367495 Free PMC article.

7

Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.

Bonner RB, Hemstreet GP 3rd, Fradet Y, Rao JY, Min KW, Hurst RE. Bonner RB, et al. Among authors: fradet y. Cancer. 1993 Oct 15;72(8):2461-9. doi: 10.1002/1097-0142(19931015)72:8<2461::aid-cncr2820720826>3.0.co;2-c. Cancer. 1993. PMID: 8402463

8

Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder.

Lee E, Schwaibold H, Fradet Y, Huland E, Huland H. Lee E, et al. Among authors: fradet y. J Urol. 1997 Mar;157(3):1070-3. J Urol. 1997. PMID: 9072545

9

Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.

Grégoire M, Fradet Y, Meyer F, Têtu B, Bois R, Bédard G, Charrois R, Naud A. Grégoire M, et al. Among authors: fradet y. J Urol. 1997 May;157(5):1660-4. J Urol. 1997. PMID: 9112500

10

Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network.

Lianes P, Charytonowicz E, Cordon-Cardo C, Fradet Y, Grossman HB, Hemstreet GP, Waldman FM, Chew K, Wheeless LL, Faraggi D. Lianes P, et al. Among authors: fradet y. Clin Cancer Res. 1998 May;4(5):1267-71. Clin Cancer Res. 1998. PMID: 9607586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters